Skip to main content

SLAS2022 Main banner

Tweets by SLAS2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Evaluation Watch Video ViewAttendees 26

On-demand recording will be available 24hrs after the presentation.

Cellular Technologies

Development and safety of cellular therapeutics

Genesis of a Phase I clinical trial for a Parkinson's disease

Monday, February 7, 2022

10:00 AM – 10:30 AM

Location: 210A

VT

Viviane Tabar, MD

Professor
Memorial Sloan Kettering Cancer Center, New York, United States

Will discuss the preclinical data leading to a trial of human ES-derived dopamine neurons for Parkinson's disease.